Intrinsic value of VistaGen Therapeutics, Inc. (VTGN)
Live fair value data for VistaGen Therapeutics, Inc. (VTGN) is currently unavailable. Please check again shortly.
Current Price: $329.00
Valuation: Undervalued
Confidence: 5.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is VistaGen Therapeutics, Inc. (VTGN) undervalued or overvalued?
Based on the current model output, VistaGen Therapeutics, Inc. appears to be undervalued with a upside of 17.00%.
Fair value vs market price — VistaGen Therapeutics, Inc. (VTGN)
Unlock premium access to view the live fair value comparison against current market price for VTGN.
Frequently Asked Questions - VTGN
How is VTGN intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for VTGN.
Is VTGN undervalued or overvalued right now?
VTGN is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for VTGN: open their intrinsic value pages.